SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-015668
Filing Date
2021-03-26
Accepted
2021-03-26 08:30:10
Documents
7
Period of Report
2021-05-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A evok-def14a_20210505.htm DEF 14A 819290
2 GRAPHIC gshgh2xoioes000002.jpg GRAPHIC 4256
3 GRAPHIC gshgh2xoioes000001.jpg GRAPHIC 17621
4 GRAPHIC gshgh2xoioes000006.jpg GRAPHIC 218653
5 GRAPHIC gshgh2xoioes000003.jpg GRAPHIC 17621
6 GRAPHIC gshgh2xoioes000005.jpg GRAPHIC 605479
7 GRAPHIC gshgh2xoioes000004.jpg GRAPHIC 4256
  Complete submission text file 0001564590-21-015668.txt   2016111
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36075 | Film No.: 21774789
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences